Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
818 Constipation
clinical trials

Constipation Clinical Trial
Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids
Status: Enrolling, Phase IV
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Efficacy and Safety of Plecanatide in Children 6 to
Status: Enrolling, Phase II
Updated: 12/31/1969
Synergy Research Site
mi
from
Houston, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Efficacy and Safety of Plecanatide in Children 6 to
Status: Enrolling, Phase II
Updated: 12/31/1969
Synergy Research Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Hospital of Carbondale
mi
from
Carbondale, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Carthage
mi
from
Carthage, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Regional Cancer System-Centralia
mi
from
Centralia, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Alegent Health Mercy Hospital
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Crossroads Cancer Center
mi
from
Effingham, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Southeastern Medical Oncology Center - Goldsboro
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
CHI Health Saint Francis
mi
from
Grand Island, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Peter's Community Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Southeastern Medical Oncology Center-Jacksonville
mi
from
Jacksonville, NC
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Heartland Hematology and Oncology
mi
from
Kearney, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Anthony Hospital
mi
from
Lakewood, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Littleton Adventist Hospital
mi
from
Littleton, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Jewish Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saints Mary and Elizabeth Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Community Medical Hospital
mi
from
Missoula, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Patrick Hospital - Community Hospital
mi
from
Missoula, MT
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Ochsner Medical Center Jefferson
mi
from
New Orleans, LA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
New Ulm Medical Center
mi
from
New Ulm, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Alegent Health Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Alegent Health Lakeside Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial GYN Plus
mi
from
Ooltewah, TN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Menorah Medical Center
mi
from
Overland Park, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Midlands Community Hospital
mi
from
Papillion, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Pekin
mi
from
Pekin, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare-Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Saint Vincent Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
North Memorial Medical Health Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Kootenai Cancer Clinic
mi
from
Sandpoint, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Medical Center-Ballard Campus
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Medical Center-First Hill
mi
from
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Lakeview Hospital
mi
from
Stillwater, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Missouri Baptist Outpatient Center-Sunset Hills
mi
from
Sunset Hills, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint John Macomb-Oakland Hospital
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Alaska Women's Cancer Care
mi
from
Anchorage, AK
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Katmai Oncology Group
mi
from
Anchorage, AK
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Charles Health System
mi
from
Bend, OR
Click here to add this to my saved trials
Irritable Bowel Syndrome Characterized by Constipation Clinical Trial
Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation
Status: Enrolling, Phase
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
North Texas Movement Disorders Institute
mi
from
Bedford, TX
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
Parkinson's and Movement Disorders Center of Maryland
mi
from
Elkridge, MD
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
Associated Neurologist of Southern CT, PC
mi
from
Fairfield, CT
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
Gastroenterology, Neurology Clinical Trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)
Status: Enrolling, Phase II
Updated: 12/31/1969
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Clinical Trials Management of Boca Raton, Inc.
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Mount Vernon Clinical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
UNC Center for Functional GI and Motility Disorders
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Family Medical Center
mi
from
Foothill Ranch, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
CRC of Jackson, LLC at Jackson Medical Clinic
mi
from
Jackson, MS
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
University of Kansas Medical Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Advanced Research Institute
mi
from
Ogden, UT
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Pivotal Research Centers
mi
from
Peoria, AZ
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Clinical Trials Research Services, LLC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Aurora Health Center
mi
from
Waukesha, WI
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Piedmont Medical Research Associates
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
North Georgia Clinical Research
mi
from
Woodstock, GA
Click here to add this to my saved trials
Constipation Clinical Trial
Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation
Status: Enrolling, Phase II
Updated: 11/26/2013
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Constipation Clinical Trial
A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults
Status: Enrolling
Updated: 9/14/2012
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Anderson, SC
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Bastrop, LA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Brandon, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Corona, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Cutler Bay, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
DeLand, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Denver, CO
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Grand Island, NE
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Huber Heights, OH
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Kinston, NC
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Lakeland, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Limerick, PA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
New Bedford, MA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
New Tazewell, TN
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Newton, KS
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Port Orange, FL
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Smyrna, GA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Snellville, GA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
Tempe, AZ
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)
Status: Enrolling, Phase III
Updated: 12/10/2015
Synergy Research Site
mi
from
West Jordan, UT
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling, Phase II
Updated: 4/25/2014
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
1 2 3 4 5 6 7 8